MARY RAYBORN

Allopathic & Osteopathic Physicians|Family Medicine SIOUX CENTER, IA NPI 1992865828

General Payments — all program years on this page

$1,141.72

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 65
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $338.94 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $338.9418

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $330.7420
2023 $472.0427
2024 $338.9418

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086172414 Bayer Healthcare Pharmaceuticals Inc. $13.73 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097258144 Novo Nordisk Inc $23.58 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097342860 Novo Nordisk Inc $19.50 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097374232 Novo Nordisk Inc $15.31 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097476405 Novo Nordisk Inc $20.50 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104201249 AstraZeneca Pharmaceuticals LP $17.27 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105391334 ABBVIE INC. $23.69 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105391338 ABBVIE INC. $15.99 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105391342 ABBVIE INC. $33.93 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105896878 AstraZeneca Pharmaceuticals LP $17.41 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115730461 GlaxoSmithKline, LLC. $13.35 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117361588 Amgen Inc. $14.42 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125380580 Abbott Laboratories $23.41 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135177461 Lilly USA, LLC $20.69 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135181692 Lilly USA, LLC $16.79 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136213914 Organon Llc $14.25 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145959976 Lundbeck LLC $14.69 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151114577 Phathom Pharmaceuticals, Inc. $20.43 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.